[PDF] Top 20 Hepatic steatosis in HIV-HCV coinfected patients in France: comparison with HCV monoinfected patients matched for body mass index and HCV genotype.
Has 10000 "Hepatic steatosis in HIV-HCV coinfected patients in France: comparison with HCV monoinfected patients matched for body mass index and HCV genotype." found on our website. Below are the top 20 most common "Hepatic steatosis in HIV-HCV coinfected patients in France: comparison with HCV monoinfected patients matched for body mass index and HCV genotype.".
Hepatic steatosis in HIV-HCV coinfected patients in France: comparison with HCV monoinfected patients matched for body mass index and HCV genotype.
... important and increasing cause of morbidity and mortality in HIV- HCV coinfected patients [14, ...prevalence and significance of steatosis in ... Voir le document complet
29
Lower ribavirin biodisponibility in patients with HIV-HCV coinfection in comparison with HCV monoinfected patients.
... Consecutive patients seen by six physicians during a 12 months period for a chronic hepatitis C infection (Edouard Herriot and Croix-Rousse hospitals, Lyon, France) and initiating a ... Voir le document complet
8
Hepatic steatosis in HIV-HCV coinfected patients receiving antiretroviral therapy is associated with HCV-related factors but not antiretrovirals.
... higher body mass index (BMI) [12,15-18,20,22,38-40,42,44] [23], hypergly- cemia [12], lower cholesterolemia [17], and presence of lipodystrophy [17] have also been found to be independ- ently ... Voir le document complet
11
Reconstitution of the entire hepatitis C virus life cycle in non-hepatic cells.: HCV life cycle in non-hepatic cells
... archive for the deposit and dissemination of sci- entific research documents, whether they are pub- lished or ...teaching and research institutions in France or abroad, or from public ... Voir le document complet
30
Does HCV screening of blood donors affect transmission of hepatitis G virus in dialysed patients?
... that HCV screening of blood donors proved to be efficient in preventing blood transfusion-transmitted HCV in our cohort of dialyzed patients without a concomitant significant effect on ... Voir le document complet
2
Efficacy of interferon-based antiviral therapy in patients with chonic hepatitis C infected HCV genotype 5: a meta-analysis of two large prospective clinical trials
... characteristics and response rate to pegy- lated interferon and ribavirin (PEG-INF þ RBV) of patients with chronic hepatitis C infected with genotype 5 are poorly ...conducted ... Voir le document complet
5
Factors associated with HCV risk practices in methadone-maintained patients: the importance of considering the couple in prevention interventions
... on HCV transmis- sion risk reduction [20,21], it is also known that methadone treatment is not enough to sufficiently reduce the HCV transmission risk in opioid-dependent individ- uals ...Indeed, ... Voir le document complet
11
Factors associated with HCV risk practices in methadone-maintained patients: the importance of considering the couple in prevention interventions
... However, in a study on a prevention intervention for couples where one or both partners were PWID, El- Bassel et ...of HIV and HCV, respectively 28% and 75%, and that a ... Voir le document complet
11
Ombitasvir/paritaprevir/ritonavir plus ribavirin for 24 weeks in patients with HCV GT4 and compensated cirrhosis (AGATE-I Part II)
... 61 patients in Arm C experienced at least one treatment ‐emergent adverse event (Table 2), the most com- mon being fatigue (n = 16 [26%]) and asthenia (n = 15 ...Three patients (5%) had severe ... Voir le document complet
10
Use of a HCV patients' education tool: the knowledge questionnaire with confidence degrees
... 13 patients? • Percentage of CA ↑ ; Average of certainties accompanying CA ↑ (93,91% to 99,84%) • A J-shaped spectral distribution of CA even more pronounced : ideal distribution (majority of CA with ... Voir le document complet
1
Increased liver stiffness is associated with mortality in HIV/HCV coinfected subjects: The French nationwide ANRS CO13 HEPAVIH cohort study
... and factors associated with mortality (p-value ...determined with a backward step- wise selection procedure among: 1/ fixed variables determined at inclusion: tobacco use, drug use, mode of ... Voir le document complet
22
Study of HCV and HIV infections in Mali: Comparative Epidemiology and Risk Factors
... of HCV and HIV infections in Mali: Comparative Epidemiology and Risk Factors Nouhoum Sama Bouare 1 *, Dolores Vaira 1 , Andre Gothot 1 , Jean Delwaide 1 , Lorence Seidel 1 , Paul Gerard ... Voir le document complet
1
Hepatitis C Virus (HCV)-Apolipoprotein Interactions and Immune Evasion and Their Impact on HCV Vaccine Design
... Lyon, France, 4 Department of Pathology, Stanford University School of Medicine, Stanford, CA, United States, 5 Institut Hospitalo-Universitaire, Pôle Hépato-digestif, Hôpitaux Universitaires de Strasbourg, ... Voir le document complet
10
New anti-HCV agents in the pipeline
... infection with hepatitis C virus (HCV) are evolving ...monotherapy in the early 90s’ to the approval of telaprevir and boceprevir based triple therapies with pegylated interferona ... Voir le document complet
2
Uncommon Detection of Mixed HCV Genotype Infections in Recently Infected Men Who Have Sex with Men
... archive for the deposit and dissemination of sci- entific research documents, whether they are pub- lished or ...teaching and research institutions in France or abroad, or from public ... Voir le document complet
17
en fr Development of novel nanovehicles for anti-HCV/HCC therapies Développement de nouveaux nanovecteurs pour les thérapies anti-HCV/HCC
... capsules for drug func- tionalization and delivery, we investigated the possibility to attach doxorubicin (DOX), an aminated anticancer drug, to DSP–BrIBAM–HSA capsules via direct conjugation to the protein ... Voir le document complet
213
SCARB1 variants and HCV infection: Host susceptibility is lost in translation
... proof-of-concept for anti-SR-BI monoclonal antibodies and a small molecule, which are in preclinical and clinical development, respectively ...variation in the SCARB1 gene has been ... Voir le document complet
11
Role of community-based research in advocating HCV prevention and care
... Health and Medical research (INSERM) and two community-based associations AIDES and MDM, to respond to a specific public health need which was to identify and evaluate innovative harm ... Voir le document complet
3
Modeling HIV-HCV coinfection epidemiology in the direct-acting antiviral era: the road to elimination
... modeled HCV transmission among HIV- infected patients only, without considering any other route of transmission such as from the monoinfected HCV ...population. In a sensitivity ... Voir le document complet
12
Good acceptability of HIV, HBV, and HCV screening during immigration medical check-up amongst migrants in France in the STRADA study
... tested for HIV or hepatitis at ...familiarity and trust in the health professionals at OFII. For one woman, the ideal setting for HIV testing was with the family ... Voir le document complet
18
Sujets connexes